Drugs & medicalType I

PMS-AMITRIPTYLINE 10 mg, 25 mg, and 50 mg: NDMA and NNORT impurity

Contamination

Read the official notice →
Date
2023-08-16
Country
Canada
Product
PMS-AMITRIPTYLINE 10 mg, 25 mg, and 50 mg
Classification
Type I
Category
Drugs & medical
Source
Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

  1. Check the product name, strength and lot number against the official notice.
  2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
  3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

  1. 2023-08-17
  2. CA
    Drugs & medicalType II

    Steris Light Handle Cover

    Performance

    Health CanadaOfficial notice →
  3. CA
    Drugs & medicalType I

    Excor System Cannulas

    Performance

    Health CanadaOfficial notice →
  4. CA
    Drugs & medicalType II

    Liquid Assayed Chemistry Control Premium Plus

    Labelling and packaging

    Health CanadaOfficial notice →
  5. 2023-08-16
  6. CA
    Drugs & medicalType I

    AMITRIPTYLINE 10 & 50mg: NDMA and NNORT impurity

    Contamination

    Health CanadaOfficial notice →
  7. CA
    Drugs & medicalType II

    Guider Softip

    Performance

    Health CanadaOfficial notice →
  8. CA
    Drugs & medicalType II

    Stryker Endoscopy Devices

    Device compatibility

    Health CanadaOfficial notice →
See all drugs & medical recalls →